Page tree
Skip to end of metadata
Go to start of metadata

 

Andrew Hurwitz

 

Dr. Hurwitz received his Ph.D. from the Albert Einstein College of Medicine in 1994, where he studied the role of the blood-brain barrier in HIV infection of the central nervous system (CNS) with Drs. Bill Lyman and Joan Berman. He continued his training at UC Berkeley as a Postdoc with Dr. Jim Allison. His studies were on the role of T cell costimulatory signals in modulating anti-tumor and autoimmune responses. In 1999, Dr. Hurwitz was appointed Assistant Professor of Microbiology and Immunology and Urology at SUNY Upstate Medical University in Syracuse, NY. His research program moved to the CCR in 2003, where he continues to study T cell tolerance to antigens relevant in anti-tumor immunity and autoimmune disease in animal models. 

Jill Suttles

Dr. Suttles is a Professor of Microbiology and Immunology at the University of Louisville School of Medicine.  She received her Ph.D. in Immunology from Brandeis University in 1986, which was followed by a postdoctoral fellowship performed at Wake Forest University Medical Center.  Prior to joining the faculty of the University of Louisville she served as Vice Chair of the Department of Biochemistry and Molecular Biology at East Tennessee State University.  Dr. Sutttles’ research is focused on inflammation in the contexts of autoimmune disease and cancer.  She has served on study sections and peer review panels for the NIH, the Arthritis Foundation, the National MS Society and the USDA, as well as on the editorial boards of the Journal of Leukocyte Biology and the Journal of Immunology.  She is currently President Elect of the Society for Leukocyte Biology.

Bob Stout

Bob Stout is currently Professor and Chair of Microbiology and Immunology at the University of Louisville School of Medicine.  He earned his Ph.D. in immunology/microbiology at the University of Michigan in 1971. After two years postdoctoral training in the Department of Pathology at Harvard Medical School and 3 years postdoctoral training in the Department of Genetics at Stanford University School of Medicine, he accepted an Assistant Professorship of Biology within the Rosenstiel Basic Medical Sciences Research Center at Brandeis University.  In 1983, he moved to the Quillen College of Medicine at East Tennessee State University as an Associate Professor of Microbiology to establish a program in immunology at that nascent medical school.  He was promoted to Professor of Microbiology and appointed Vice-Chair of Microbiology in 1989 and subsequently became interim Chair.  He was recruited into the Chair of Microbiology and Immunology at the University of  Louisville School of Medicine in 1999.  During the past 10 years, the number of faculty in the Department has increased 3-fold, the Departmental Graduate program has increased 5-fold, and the extramural funding has increased 20-fold.  The programmatic growth in immunology was integrated with the Institute for Cellular Therapeutics and the James Graham Brown Cancer Center to establish an interdisciplinary and multi-departmental research and educational program in basic and translational immunology. 

 

Robert H. Wiltrout

 

Robert H. Wiltrout, Ph.D., is the Director of the Center for Cancer Research (CCR), home to the basic, clinical, and translational research enterprise located within the National Cancer Institute in suburban Washington, D.C. and Frederick, Maryland. He also serves as a member of NCI’s Executive Committee which provides advice and counsel to the NCI Director. Dr. Wiltrout has also been the recipient of two NIH merit awards, and multiple Federal Technology Transfer Awards. He has been Visiting Professor of Immunology at the University of Rome in Rome, Italy and is a longstanding member of the American Association of Immunology, the American Association of Cancer Research, the Society for Leukocyte Biology, the Society for Natural Immunity, and the Society for Biological Therapy.

 

 

  • No labels